Jin-Ding Huang
Senhwa Biosciences
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jin-Ding Huang as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:50 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05817708 · A Study of Silmitasertib (CX-4945) in Healthy SubjectSenhwa Biosciences, Inc. · completed · COVID-19 · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:50 UTC. The ranking covers the 200 most relevant of 1646 PubMed records, and a shared surname and initials can bring in a namesake. All 1646 on PubMed
- 689 citationsRCR 34.6
- 627 citationsRCR 54.7
- 410 citationsRCR 17.3
- 408 citationsRCR 19.3
- 262 citationsRCR 16.6
- Kidney damage causally affects the brain cortical structure: A Mendelian randomization study.EBioMedicine · 2021221 citationsRCR 13.9
- 208 citationsRCR 20.3
- 198 citationsRCR 12.9
- 193 citationsRCR 16.8
- 192 citationsRCR 9.1